BioCatalyst

Alectinib, Entrectinib, Durvalumab — catalyst calendar

1 verified catalyst event(s) referencing Alectinib, Entrectinib, Durvalumab, each linked to its official source. Verified as of 2026-11-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-19
in 3mo
ESTIMATED
 READOUT
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of P
Phase 3 · Non-Small Cell Lung Cancer
 Hoffmann-La Roche Alectinib, Entrectinib, Durvalumab ClinicalTrials.gov ↗
✓ Source-checked 2026-11-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.